To include your compound in the COVID-19 Resource Center, submit it here.

Passage Bio debuts with $115.5M for CNS gene therapies

Co-founded by gene therapy pioneer James Wilson, Passage Bio Inc. (Philadelphia, Pa.) launched with $115.5 million in series A

Read the full 192 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE